Treatments

hospital-834152_12801.jpg
Read March 18, 2019

Access to CAR T Cell Therapies for Medicare Patients

The Centers for Medicare and Medicaid Services (CMS) have recently released a National Coverage Analysis memo to decide how CMS will provide coverage for this innovative treatment. They have proposed coverage alongside a concept known as “evidence development.”